Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease
-
Narrated by:
-
Written by:
About this listen
The latest episode of Optimum Perspectives Podcast has just dropped, featuring LoQus23 Therapeutics’ Chief Scientific Officer and founder Caroline Benn!
Listen as Caroline details the devastating effects of Huntington’s Disease on patients and families, her personal motivations for working in this therapeutic area, as well as LoQus23’s unique approach to battling the disease through their innovative small molecule approach.
Hosted on Acast. See acast.com/privacy for more information.
No reviews yet